Search Results - "Kopin, I J"

Refine Results
  1. 1

    The analgesic effects of R(+)-WIN 55,212–2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain by Herzberg, U, Eliav, E, Bennett, G.J, Kopin, Irwin J

    Published in Neuroscience letters (17-01-1997)
    “…The effects of a high affinity cannabinoid receptor agonist were evaluated in rats subjected to chronic constriction injury of the sciatic nerve (CCI) or a…”
    Get full text
    Journal Article
  2. 2

    Catechols in post-mortem brain of patients with Parkinson disease by Goldstein, D. S., Sullivan, P., Holmes, C., Kopin, I. J., Basile, M. J., Mash, D. C.

    Published in European journal of neurology (01-05-2011)
    “…Background:  Dihydroxyphenylacetaldehyde (DOPAL), a cytotoxic metabolite of dopamine, is the focus of the ‘catecholaldehyde hypothesis’ about the pathogenesis…”
    Get full text
    Journal Article
  3. 3

    Sympathetic Cardioneuropathy in Dysautonomias by Goldstein, David S, Holmes, Courtney, Cannon, Richard O, Eisenhofer, Graeme, Kopin, Irwin J

    Published in The New England journal of medicine (06-03-1997)
    “…Dysautonomias, derangements of sympathetic or parasympathetic nervous system function, are seen fairly often in neurology and cardiology. Autonomic…”
    Get full text
    Journal Article
  4. 4

    Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells by Goldstein, David S, Jinsmaa, Yunden, Sullivan, Patti, Holmes, Courtney, Kopin, Irwin J, Sharabi, Yehonatan

    “…According to the catecholaldehyde hypothesis, the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL) contributes to the loss of nigrostriatal…”
    Get more information
    Journal Article
  5. 5

    Cardiac sympathetic nerve function in congestive heart failure by EISENHOFER, G, FRIBERG, P, RUNDQVIST, B, QUYYUMI, A. A, LAMBERT, G, KAYE, D. M, KOPIN, I. J, GOLDSTEIN, D. S, ESLER, M. D

    Published in Circulation (New York, N.Y.) (01-05-1996)
    “…Increased availability of norepinephrine (NE) for activation of cardiac adrenoceptors (increased cardiac adrenergic drive) and depletion of myocardial NE…”
    Get full text
    Journal Article
  6. 6

    3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells by Lamensdorf, Itschak, Eisenhofer, Graeme, Harvey-White, Judith, Nechustan, Amotz, Kirk, Kenneth, Kopin, Irwin J.

    Published in Brain research (23-06-2000)
    “…3,4-Dihydroxyphenylacetaldehyde (DOPAL) is a toxic metabolite formed by the oxidative deamination of dopamine. This aldehyde is mainly oxidized to…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Endogenous serotonin stimulates striatal dopamine release in conscious rats by Yadid, G, Pacak, K, Kopin, I J, Goldstein, D S

    “…Serotonin (5-HT) and dopamine (DA) are established neurotransmitters in the brain. This study examined whether, in conscious, free-moving rats, increased…”
    Get more information
    Journal Article
  9. 9

    Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde by Lamensdorf, I., Eisenhofer, G., Harvey-White, J., Hayakawa, Y., Kirk, K., Kopin, I.J.

    Published in Journal of neuroscience research (15-05-2000)
    “…3,4‐Dihydroxyphenylacetaldehyde (DOPAL) has been reported to be a toxic metabolite formed by the oxidative‐deamination of dopamine (DA) catalyzed by monoamine…”
    Get full text
    Journal Article
  10. 10

    MPTP toxicity: implications for research in Parkinson's disease by Kopin, I J, Markey, S P

    Published in Annual review of neuroscience (01-01-1988)
    “…In summary, the parkinsonism induced by MPTP in man closely resembles time-telescoped Parkinson's disease. Parkinsonian symptoms can be duplicated in all…”
    Get full text
    Journal Article
  11. 11

    Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase by Eisenhofer, G, Goldstein, D S, Stull, R, Keiser, H R, Sunderland, T, Murphy, D L, Kopin, I J

    Published in Clinical chemistry (Baltimore, Md.) (01-11-1986)
    “…This is a reversed-phase liquid-chromatographic method, with electrochemical detection, for simultaneously measuring, in plasma, the concentrations of the…”
    Get more information
    Journal Article
  12. 12

    Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats by Kvetnanský, R, Fukuhara, K, Pacák, K, Cizza, G, Goldstein, D S, Kopin, I J

    Published in Endocrinology (Philadelphia) (01-09-1993)
    “…Cardiovascular and metabolic adjustments during stress involve participation of the sympatho-adrenal and hypothalamic-pituitary-adrenocortical systems, which…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes by Lenders, J W, Eisenhofer, G, Abeling, N G, Berger, W, Murphy, D L, Konings, C H, Wagemakers, L M, Kopin, I J, Karoum, F, van Gennip, A H, Brunner, H G

    Published in The Journal of clinical investigation (15-02-1996)
    “…Monoamine oxidase (MAO) exists as two isoenzymes and plays a central role in the metabolism of monoamine neurotransmitters. In this study we compared the…”
    Get full text
    Journal Article
  16. 16

    Determination of metanephrines in plasma by liquid chromatography with electrochemical detection by Lenders, J W, Eisenhofer, G, Armando, I, Keiser, H R, Goldstein, D S, Kopin, I J

    Published in Clinical chemistry (Baltimore, Md.) (01-01-1993)
    “…Metanephrines are O-methylated metabolites of catecholamines. We report the use of liquid chromatography with electrochemical detection to determine plasma…”
    Get more information
    Journal Article
  17. 17

    Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans by GOLDSTEIN, D. S, EISENHOFER, G, STULL, R, FOLIO, C. J, KEISER, H. R, KOPIN, I. J

    “…We examined plasma levels of the sympathetic neurotransmitter norepinephrine (NE) and its deaminated metabolite dihydroxyphenylglycol (DHPG) during supine rest…”
    Get full text
    Journal Article
  18. 18

    Effects of immobilization on in vivo release of norepinephrine in the bed nucleus of the stria terminalis in conscious rats by Pacak, Karel, McCarty, Richard, Palkovits, Miklos, Kopin, Irwin J., Goldstein, David S.

    Published in Brain research (07-08-1995)
    “…Release of norepinephrine (NE) and its metabolites in the bed nucleus of the stria terminalis (BNST) was examined using in vivo microdialysis in conscious rats…”
    Get full text
    Journal Article
  19. 19

    Induction of Tyrosine Hydroxylase Gene Expression by a Nonneuronal Nonpituitary-Mediated Mechanism in Immobilization Stress by Nankova, Bistra, Kvetnansky, Richard, McMahon, Anne, Viskupic, Emil, Hiremagalur, Bhargava, Frankle, Gordon, Fukuhara, Koki, Kopin, Irwin J., Sabban, Esther L.

    “…Stress stimulates the sympathoadrenal system, causing activation of the catecholamine biosynthetic enzymes. Here we examine the changes of gene expression of…”
    Get full text
    Journal Article
  20. 20

    Structural properties of phenylethylamine derivatives which inhibit transport‐P in peptidergic neurones by Al‐Damluji, S, Kopin, I J

    Published in British journal of pharmacology (01-06-1998)
    “…Transport‐P is an antidepressant‐sensitive, proton‐dependent, V‐ATPase‐linked uptake process for amines in peptidergic neurones of the hypothalamus. It is…”
    Get full text
    Journal Article